Relationship Between Sensor-Detected Hypoglycemia and Patient-Reported Hypoglycemia in People With Type 1 and Insulin-Treated Type 2 Diabetes: The Hypo-METRICS Study

The novel findings are that at least half of CGM hypoglycemia is asymptomatic, even below 54 mg/dL, and many reported symptomatic hypoglycemia episodes happen above 70 mg/dL. In the clinical and research setting, these episodes cannot be used interchangeably, and both need to be recorded and addressed.

Authors

Institutions

Publication Details

Journal
Diabetes Care
Published
2024-08-29
DOI
https://doi.org/10.2337/dc23-2332
Citations
26
Primary Topic
Diabetes Management and Research
Type
article
Field-Weighted Citation Impact
9.30

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Relationship Between Sensor-Detected Hypoglycemia and Patient-Reported Hypoglycemia in People With Type 1 and Insulin-Treated Type 2 Diabetes: The Hypo-METRICS Study

Stephanie A. Amiel, Frans Pouwer, Monika Cigler, Ulrik Pedersen‐Bjergaard et al.
26 citations
Diabetes Care
Diabetes Management and Research
9.30
article

Relationship Between Sensor-Detected Hypoglycemia and Patient-Reported Hypoglycemia in People With Type 1 and Insulin-Treated Type 2 Diabetes: The Hypo-METRICS Study

Stephanie A. Amiel, Frans Pouwer, Monika Cigler, Ulrik Pedersen‐Bjergaard, Namam Ali, Julia Katharina Mader, Uffe Søholm, Pratik Choudhary, Éric Renard, Julie Maria Bøggild Brøsen, Rory J. McCrimmon, Simon Heller, Zeinab Mahmoudi, Mark L. Evans, Patrick Divilly, Bastiaan E. de Galan, Gilberte Martine‐Edith, Allan Vaag, Evertine J. Abbink, Natalie Zaremba
article en
26 citations

Abstract

The novel findings are that at least half of CGM hypoglycemia is asymptomatic, even below 54 mg/dL, and many reported symptomatic hypoglycemia episodes happen above 70 mg/dL. In the clinical and research setting, these episodes cannot be used interchangeably, and both need to be recorded and addressed.

Diabetes CareVol. 47(10)
University College Dublin (IE), University of Copenhagen (DK), Centre National de la Recherche Scientifique (FR), Steno Diabetes Centers (DK), Radboud University Nijmegen (NL), University of Leicester (GB), Inserm (FR), University of Dundee (GB), University of Southern Denmark (DK), King's College London (GB), Novo Nordisk (Denmark) (DK), Université de Montpellier (FR), Medical University of Graz (AT), Copenhagen University Hospital (DK), Radboud University Medical Center (NL), Maastricht University (NL), Zealand University Hospital (DK), Centre Hospitalier Universitaire de Montpellier (FR), Novo Nordisk (United States) (US), St. Vincent's University Hospital (IE), Wellcome/MRC Institute of Metabolic Science (GB), King's College School (GB), Danish Diabetes Association (DK), NIHR Leicester Biomedical Research Centre (GB), University of Sheffield (GB)
Juvenile Diabetes Research Foundation International, Eli Lilly and Company, Sanofi, Leona M. and Harry B. Helmsley Charitable Trust, University of Dundee, European Federation of Pharmaceutical Industries and Associations, National Institute for Health and Care Research, Department of Health and Social Care, King's College London, European Commission, Radboud Universiteit, Novo Nordisk, Université de Montpellier, Innovative Medicines Initiative, Abbott Diabetes Care, Menzies Centre for Australian Studies, King's College London, University of London, NIHR Cambridge Biomedical Research Centre
Good health and well-being
Openalex Percentile: Top 2%
Diabetes Management and Research
9.30
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.